𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of Recombinant Interleukin-2 for Intrapleural Therapy of Tumor-Associated Pleurisy

✍ Scribed by K. S. Titov; M. V. Kiselevskii; L. V. Demidov; I. N. Mikhailova; I. Zh. Shubina; L. M. Rodionova; I. E. Sinel’nikov; K. Yu. Topol’; A. N. Gritsai

Book ID
106358587
Publisher
Springer US
Year
2009
Tongue
English
Weight
246 KB
Volume
148
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dualistic effects of cis-diammine-dichlo
Dualistic effects of cis-diammine-dichloro-platinum on the anti-tumor efficacy of subsequently applied recombinant interleukin-2 therapy: A tumor-dependent phenomenon
✍ Moniquc R. Bernsen; A. Peter M. Heintz; Harrold J. J. Van Barungen; Alike W. Van 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 616 KB

The efficacy with which disseminated SL2 and P815 tumors, in syngeneic DBA/2 mice, can be eradicated with low-dose recombinant interleukin-2 (rlL-2) therapy is about equal. Treatment (i.p.) of DBA/2 mice, injected i.p. with SL2 or P8 I5 cells on day 0, with rlL-2 (Proleukin) on days 10 to 14 results

Phenotypic and functional characteristic
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin-2 (ril-2)
✍ Giovanni Melioli; Editta Baldini; Maria Cristina Mingari; Andrea De Maria; Mario 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 466 KB

In the course of a phase I trial, in which recombinant IL-2 (rlL-2) was infused intraperitoneally (i.p.) in patients with peritoneal carcinomatosis, we evaluated the effect on "tumorassociated lymphocytes" (TAL) isolated from the axitic fluid. No major changes in the percentages of cells expressing